Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.
about
Metallothionein and stress combine to affect multiple organ systemsMetalation kinetics of the human α-metallothionein 1a fragment is dependent on the fluxional structure of the apo-protein.Mammalian Metallothionein-3: New Functional and Structural InsightsAdvances in the molecular understanding of biological zinc transport.Systematic review of the relationship between amyloid-β levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease.Time dynamics of protein complexes in the AD11 transgenic mouse model for Alzheimer's disease like pathology.Fluorescence-tagged metallothionein with CdTe quantum dots analyzed by the chip-CE technique.Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus.Zinc and the aging brainMetallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies.Metallothionein polymorphisms in pathological processes.The role of metallothionein interactions with other proteins.Metallothioneins in Prion- and Amyloid-Related Diseases.Metallothionein-III increases ADAM10 activity in association with furin, PC7, and PKCα during non-amyloidogenic processing.Thermodynamics of Pb(ii) and Zn(ii) binding to MT-3, a neurologically important metallothionein.Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.The Efficacy and Pharmacological Mechanism of Zn7MT3 to Protect against Alzheimer's Disease.Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.
P2860
Q26821920-E7BF95DE-D321-42A2-85A4-A39D385137DAQ30368724-3996871B-9B00-45D9-A73B-15253F253C7FQ33838378-F242B077-DA96-41A2-A6C4-4B385BBAA88CQ34459994-3D3DC399-BD53-4218-A836-959B3500CE7AQ35137134-6F80A782-534E-4867-BB01-C7045AF2809DQ35618276-14AEA555-C6D2-4A0A-B67F-7DBCBB5948E4Q36220811-2C612D1D-582E-4A91-A1D5-AC2E08B1B56FQ36490385-BFC7991C-8B34-4676-BA95-7306632A67C8Q37496663-E36269E0-EF75-4285-9583-91654A24731FQ37737068-AE5930DE-298F-4A29-B97D-AFCEDDD6C93CQ38143589-3AB4B1DB-579E-4393-AC80-5551FBF4ABDAQ38195009-C2CD21D0-328A-409E-9737-19730120616CQ38753411-CB9768E0-E8CA-4CE4-BC89-BD134F52542CQ38991860-0DC9C35C-59A0-47EB-B40A-571CD444BABFQ40116945-E380D167-F5D0-449C-B931-A9F38C7CD2D9Q45923792-6C00C7A6-6D90-43F0-A2F1-CE10A9B50F2EQ46331404-D3FD26D4-8E14-444C-93E2-9C83122FC2A3Q47575296-5D9C6B8A-CD2D-4C55-8268-2C88EC1F9826
P2860
Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Characterization of the role o ...... model of Alzheimer's disease.
@en
Characterization of the role o ...... model of Alzheimer's disease.
@nl
type
label
Characterization of the role o ...... model of Alzheimer's disease.
@en
Characterization of the role o ...... model of Alzheimer's disease.
@nl
prefLabel
Characterization of the role o ...... model of Alzheimer's disease.
@en
Characterization of the role o ...... model of Alzheimer's disease.
@nl
P2093
P2860
P50
P1476
Characterization of the role o ...... model of Alzheimer's disease.
@en
P2093
Gemma Comes
Milan Vašák
Paul A Adlard
Yasmina Manso
P2860
P2888
P304
P356
10.1007/S00018-012-1047-9
P577
2012-06-22T00:00:00Z